The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Homologous recombination repair (HRR) mutation concordance between liquid biopsy (LB) and tumor tissue by NGS in a real-world prostate cancer (PC) database.
 
John Shen
Consulting or Advisory Role - AstraZeneca; Bayer; Kite/Gilead; Sanofi
Research Funding - Ambrx (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Exelixis (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Kite/Gilead; Sanofi
 
Liang Wang
No Relationships to Disclose
 
Ali Raza Khaki
Honoraria - OncLive/MJH Life Sciences
Other Relationship - Tempus
(OPTIONAL) Uncompensated Relationships - Seattle Genetics/Astellas
 
Rafael E Jimenez
Consulting or Advisory Role - Histowiz
Patents, Royalties, Other Intellectual Property - Royalties for published books: Elsevier and Springer
 
Elizabeth Mauer
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - Tempus
 
Melissa Conrad Stoppler
Employment - Exact Sciences; Gilead Sciences (I); Roche/Genentech (I); Roche/Genentech (I); Tempus
Stock and Other Ownership Interests - Exact Sciences; Roche/Genentech (I); Tempus
 
Calvin Y. Chao
Employment - Exact Sciences; Tempus
Leadership - Exact Sciences; Tempus
Stock and Other Ownership Interests - Exact Sciences; Tempus
 
Manish Kohli
Employment - nference (I)
Honoraria - Advanced Accelerator Applications
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Genapsys; Tempus
Patents, Royalties, Other Intellectual Property - Patent number: 10982286. Algorithmic approach for determining the plasma genome abnormality PGA and the urine genome abnormality UGA scores based on cell free cfDNA copy number variations in plasma and urine
Travel, Accommodations, Expenses - Celgene